NETEC Resource Library

Inpatient COVID-19 Outcomes in Solid Organ Transplant Recipients Compared to Non-Solid Organ Transplant Patients: A Retrospective Cohort

Contenu

Click for External Resource*


Click to read full article*


*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.


Item Type

Publication

Terms of Use

By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.

Was this resource helpful?


Titre

Inpatient COVID-19 Outcomes in Solid Organ Transplant Recipients Compared to Non-Solid Organ Transplant Patients: A Retrospective Cohort

Sujet

Description

Immunosuppression and comorbidities might place solid organ transplant (SOT) recipients at higher risk from COVID-19, as suggested by recent case series. We compared 45 SOT vs 2427 non-SOT patients who were admitted with COVID-19 to our health-care system (3/1/20-8/21/20), evaluating hospital length-of-stay and inpatient mortality using competing risks regression.

Date

2020-12-07

Citer ce document

Avery, R. K., T. P. Chiang, K. A. Marr, D. C. Brennan, A. S. Sait, B. T. Garibaldi, P. Shah, D. Ostrander, S. Mehta Steinke, N. Permpalung, W. Cochran, M. A. Makary, J. Garonzik-Wang, D. L. Segev, and A. B. Massie. 2020. "Inpatient COVID-19 Outcomes in Solid Organ Transplant Recipients Compared to Non-Solid Organ Transplant Patients: A Retrospective Cohort." Am J Transplant.

Résumé

Immunosuppression and comorbidities might place solid organ transplant (SOT) recipients at higher risk from COVID-19, as suggested by recent case series. We compared 45 SOT vs 2427 non-SOT patients who were admitted with COVID-19 to our health-care system (3/1/20-8/21/20), evaluating hospital length-of-stay and inpatient mortality using competing risks regression. We compared trajectories of WHO COVID-19 severity scale using mixed-effects ordinal logistic regression, adjusting for severity score at admission. SOT and non-SOT patients had comparable age, sex, and race, but SOT recipients were more likely to have diabetes (60% vs. 34%, p < 0.001), hypertension (69% vs. 44%, p = 0.001), HIV (7% vs 1.4%, p = 0.024), and peripheral vascular disorders (19% vs. 8%, p = 0.018). There were no statistically significant differences between SOT and non-SOT in maximum illness severity score (p = 0.13), length-of-stay (sHR=0.9 1.11.4 , p = 0.5), or mortality (sHR:0.1 0.41.6 , p = 0.19), although the severity score on admission was slightly lower for SOT (median (IQR) 3 (3, 4)) than for non-SOT (median (IQR) 4 (3-4)), (p = 0.042) Despite a higher risk profile, SOT recipients had a faster decline in disease severity over time (OR=0.76 0.810.86 , p < 0.001) compared with non-SOT patients. These findings have implications for transplant decision-making during the COVID-19 pandemic, and insights about the impact of SARS-CoV-2 on immunosuppressed patients.

Accessibilité

Free online on Wiley Online Library.

Collection